Correlation Engine 2.0
Clear Search sequence regions


  • behaviors (2)
  • cannabis (14)
  • ecosystem (2)
  • hallucinogens (2)
  • help (1)
  • humans (1)
  • marijuana (1)
  • public health (4)
  • thc (1)
  • Sizes of these terms reflect their relevance to your search.

    Different patterns of cannabis use can be traced directly back to different interactions between 2 types of variables: pharmacological and environmental. As legal cannabis expands in the U.S. and around the world, state and national regulatory agencies are gaining control over these variables. Specifically, regulatory agencies are increasingly capable of altering (a) the pharmacological properties of cannabis products and (b) the way these products are distributed to the population. Consequently, cannabis regulatory agencies are in a unique position to use evidence from psychological science to alter cannabis consumption patterns in ways that mitigate potential harm to public health. However, most state-level legal cannabis regulatory systems in the U.S. are not yet evidence-based or public health-oriented. This applied review and commentary draws on evidence from the psychological science literature to help regulators better understand the types of behaviors they must address and guide empirically supported regulation of THC-laden cannabis, whether used putatively for medical or recreational reasons. This review is organized into 3 parts that correspond to the 3 primary agents within the cannabis regulation ecosystem: (a) the cannabis consumer, (b) the cannabis industry, and (c) the cannabis regulatory agency. Within this structure, the review addresses critical psychological variables that drive cannabis consumer and industry behaviors and discusses how regulatory agencies can use this information to protect public health. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

    Citation

    Jacob T Borodovsky, Michael J Sofis, Richard A Grucza, Alan J Budney. The importance of psychology for shaping legal cannabis regulation. Experimental and clinical psychopharmacology. 2021 Feb;29(1):99-115

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32437193

    View Full Text